Endothelin receptors A and B (EDNRA, and EDNRB) have altered expression levels in multiple cancers, such as colorectal, bladder, prostate, and nasopharyngeal carcinomas, in addition to cervical cancer. This evidence concerns the gene EDNRB and cancer.